Dexur helps Medical Device Organizations succeed by providing critical hospital specific quality outcomes & data.
Click here to learn about Dexur’s plans, pricing and benefits for Medical Device Organizations.
SCANLAN® In Situ Valvulotomes - SCANLAN INTERNATIONAL INC - In Depth Guide
Table of Contents
SCANLAN INTERNATIONAL INC - SCANLAN® In Situ Valvulotomes : Product InformationBack to Top
SCANLAN® In Situ Valvulotomes
In Commercial Distribution
SCANLAN INTERNATIONAL INC
In Commercial Distribution
SCANLAN INTERNATIONAL INC
00846159032000
GS1
NA
1
GS1
NA
1
Valvulotome
SCANLAN® In Situ Valvulotomes - Device Characteristics
| MRI safety Status | Labeling does not contain MRI Safety Information |
|---|---|
| Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437) | No |
| Device labeled as "Not made with natural rubber latex" | No |
| For Single-Use | No |
| Prescription Use (Rx) | True |
| Over the Counter (OTC) | No |
| Kit | No |
| Combination Product | No |
| Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P) | No |
SCANLAN® In Situ Valvulotomes - GMDN
| GMDN Preferred Term Name | GMDN Definition |
|---|---|
| Valvulotome | A hand-held manual surgical instrument designed for cutting an anatomical valve or valves in situ (e.g., to slit a heart valve or to cut the valves within a vein to allow blood flow in the opposite direction). It is typically a flexible, plastic-coated metal shaft with a proximal handle and an extremely sharp cutting edge at the distal tip (e.g., the distal tip may terminate in a blade which is curved at 90 degrees to the shaft, or an assembly of several thin helicoidal blades that are rotated). This is a reusable device. |
SCANLAN® In Situ Valvulotomes - Sterilization
No
true
SCANLAN INTERNATIONAL INC - SCANLAN® In Situ Valvulotomes : Product Code InformationBack to Top
FDA Product Code
| Product Code | Product Code Name |
|---|---|
| MGZ | Valvulotome |
SCANLAN INTERNATIONAL INC - SCANLAN® In Situ Valvulotomes : Reimbursement Data & Quality OutcomesBack to Top
This sample data is for Yale New Haven Hospital & shows the reimbursement and quality outcomes data to help understand the the ROI, Business Case, HEOR & VAC Metrics in the use SCANLAN® In Situ Valvulotomes by SCANLAN INTERNATIONAL INC.
To get metrics for your Hospital, click here.
Quality Outcomes Data from Medicare Claims Analysis
| Jan 2017 to Dec 2017 Medicare Hospitalizations | Jan 2013 to Dec 2017 Medicare Hospitalizations | |
|---|---|---|
| Inpatient (For Included Categories & DRGs) | 181 | 870 |
| Non Surgical (For Included Categories & DRGs) | 181 | 870 |
| Cardiovascular (For Included DRGs) | 181 | 870 |
| PERIPHERAL VASCULAR DISORDERS | 181 | 870 |
Inpatient Quality Outcomes Data from Medicare Claims Analysis | Back to Reimbursement Quality Outcomes Summary
Data with Symbol is for Dexur Pro Members. Get a Demo and know more.
| Inpatient All (For Included Categories & DRGs) | Inpatient - Non Surgical (For Included Categories & DRGs) | |||
|---|---|---|---|---|
| Jan 2017 to Dec 2017 | Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017 | Jan 2013 to Dec 2017 | |
| Total Hospitalizations | 181 | 870 | 181 | 870 |
| Total Hospitalizations After Exclusion | 172 | 821 | 172 | 821 |
| Avg. LOS | 4.10 | 4.42 | 4.10 | 4.42 |
| All Cause Readmission Rate (%) | ||||
| Unplanned Readmission Rate (%) | ||||
| ICU Stays | ||||
| Avg. Number of Days in ICU per ICU Stay | ||||
| Total Medicare Payments | $1,557,819 | $8,154,220 | $1,557,819 | $8,154,220 |
| Payment per Day | $2,099 | $2,119 | $2,099 | $2,119 |
| Payment per Hospitalization | $8,606 | $9,372 | $8,606 | $9,372 |
| Total Medicare Charges | $6,149,265 | $33,438,065 | $6,149,265 | $33,438,065 |
| Avg. Charges | $33,974 | $38,435 | $33,974 | $38,435 |
| Mortality Rate (%) | ||||
| SNF Discharge Rate (%) | 20.44 | 22.87 | 20.44 | 22.87 |
| Home Discharge Rate (%) | 31.49 | 32.76 | 31.49 | 32.76 |
| Peripheral Vascular Disease | ||||
| Total Hospitalizations with Peripheral Vascular Disease | ||||
| Total Hospitalizations After Exclusion with Peripheral Vascular Disease | ||||
| Avg. LOS with Peripheral Vascular Disease | ||||
| 30 Day Peripheral Vascular Disease Readmission Rate (%) | ||||
| 30 Day Readmission Rate with Peripheral Vascular Disease(%) | ||||
| 30 Day Peripheral Vascular Disease Unplanned Readmission Rate (%) | ||||
| ICU Stays with Peripheral Vascular Disease | ||||
| Avg. Number of Days in ICU per ICU Stay with Peripheral Vascular Disease | ||||
| Medicare Payments with Peripheral Vascular Disease | ||||
| Payment per Day with Peripheral Vascular Disease | ||||
| Payment per Hospitalization with Peripheral Vascular Disease | ||||
| Medicare Charges with Peripheral Vascular Disease | ||||
| Avg. Charges with Peripheral Vascular Disease | ||||
| Inpatient Hospital Mortality Rate (%) with Peripheral Vascular Disease | ||||
| SNF Discharge Rate (%) with Peripheral Vascular Disease | ||||
| Home Discharge Rate (%) with Peripheral Vascular Disease | ||||
| Incidence Rate (%) with Peripheral Vascular Disease | ||||
| Incidence Rate (%) with Peripheral Vascular Disease after Exclusions | ||||
Top ICD Diagnosis Codes For Inpatient (For Included Categories & DRGs) | Back to Reimbursement Quality Outcomes Summary
Data with Symbol is for Dexur Pro Members. Get a Demo and know more.
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | Total ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume - Jan 2013 to Dec 2017 | % of DRG Volume - Jan 2017 to Dec 2017 |
|---|---|---|---|---|---|
| 4019 | Unspecified essential hypertension | 233 | NA | 26.78 | NA |
Top Procedure Codes For Inpatient (For Included Categories & DRGs) | Back to Reimbursement Quality Outcomes Summary
Data with Symbol is for Dexur Pro Members. Get a Demo and know more.
| Procedure Code | Procedure Description | Total Procedure Code & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | Total Procedure Code & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume - Jan 2013 to Dec 2017 | % of DRG Volume - Jan 2017 to Dec 2017 |
|---|---|---|---|---|---|
| 9919 | 46 | NA | 5.29 | NA | |
Cardiovascular Quality Outcomes Data from Medicare Claims Analysis | Back to Reimbursement Quality Outcomes Summary
Data with Symbol is for Dexur Pro Members. Get a Demo and know more.
| Cardiovascular (For Included DRGs) | Cardiovascular - Non Surgical (For Included DRGs) | |||
|---|---|---|---|---|
| Jan 2017 to Dec 2017 | Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017 | Jan 2013 to Dec 2017 | |
| Total Hospitalizations | 181 | 870 | 181 | 870 |
| Total Hospitalizations After Exclusion | 172 | 821 | 172 | 821 |
| Avg. LOS | 4.10 | 4.42 | 4.10 | 4.42 |
| All Cause Readmission Rate (%) | ||||
| Unplanned Readmission Rate (%) | ||||
| ICU Stays | ||||
| Avg. Number of Days in ICU per ICU Stay | ||||
| Total Medicare Payments | $1,557,819 | $8,154,220 | $1,557,819 | $8,154,220 |
| Payment per Day | $2,099 | $2,119 | $2,099 | $2,119 |
| Payment per Hospitalization | $8,606 | $9,372 | $8,606 | $9,372 |
| Total Medicare Charges | $6,149,265 | $33,438,065 | $6,149,265 | $33,438,065 |
| Avg. Charges | $33,974 | $38,435 | $33,974 | $38,435 |
| Mortality Rate (%) | ||||
| SNF Discharge Rate (%) | 20.44 | 22.87 | 20.44 | 22.87 |
| Home Discharge Rate (%) | 31.49 | 32.76 | 31.49 | 32.76 |
| Peripheral Vascular Disease | ||||
| Total Hospitalizations with Peripheral Vascular Disease | ||||
| Total Hospitalizations After Exclusion with Peripheral Vascular Disease | ||||
| Avg. LOS with Peripheral Vascular Disease | ||||
| 30 Day Peripheral Vascular Disease Readmission Rate (%) | ||||
| 30 Day Readmission Rate with Peripheral Vascular Disease(%) | ||||
| 30 Day Peripheral Vascular Disease Unplanned Readmission Rate (%) | ||||
| ICU Stays with Peripheral Vascular Disease | ||||
| Avg. Number of Days in ICU per ICU Stay with Peripheral Vascular Disease | ||||
| Medicare Payments with Peripheral Vascular Disease | ||||
| Payment per Day with Peripheral Vascular Disease | ||||
| Payment per Hospitalization with Peripheral Vascular Disease | ||||
| Medicare Charges with Peripheral Vascular Disease | ||||
| Avg. Charges with Peripheral Vascular Disease | ||||
| Inpatient Hospital Mortality Rate (%) with Peripheral Vascular Disease | ||||
| SNF Discharge Rate (%) with Peripheral Vascular Disease | ||||
| Home Discharge Rate (%) with Peripheral Vascular Disease | ||||
| Incidence Rate (%) with Peripheral Vascular Disease | ||||
| Incidence Rate (%) with Peripheral Vascular Disease after Exclusions | ||||
Top ICD Diagnosis Codes for Cardiovascular (For Included Categories & DRGs) | Back to Reimbursement Quality Outcomes Summary
Data with Symbol is for Dexur Pro Members. Get a Demo and know more.
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | Total ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume - Jan 2013 to Dec 2017 | % of DRG Volume - Jan 2017 to Dec 2017 |
|---|---|---|---|---|---|
| 4019 | Unspecified essential hypertension | 233 | NA | 26.78 | NA |
Top Procedure Codes for Cardiovascular (For Included Categories & DRGs) | Back to Reimbursement Quality Outcomes Summary
Data with Symbol is for Dexur Pro Members. Get a Demo and know more.
| Procedure Code | Procedure Description | Total Procedure Code & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | Total Procedure Code & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume - Jan 2013 to Dec 2017 | % of DRG Volume - Jan 2017 to Dec 2017 |
|---|---|---|---|---|---|
| 9919 | 46 | NA | 5.29 | NA | |
DRG Group : PERIPHERAL VASCULAR DISORDERS Quality Outcomes Data from Medicare Claims Analysis | Back to Reimbursement Quality Outcomes Summary
Data with Symbol is for Dexur Pro Members. Get a Demo and know more.
| PERIPHERAL VASCULAR DISORDERS - Cardiovascular | DRG 300 : PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY | DRG 299 : PERIPHERAL VASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY | DRG 301 : PERIPHERAL VASCULAR DISORDERS WITHOUT COMPLICATION OR COMORBIDITY/MAJOR COMPLICATION OR COMORBIDITY | |||||
|---|---|---|---|---|---|---|---|---|
| DRG Group | PERIPHERAL VASCULAR DISORDERS | PERIPHERAL VASCULAR DISORDERS | PERIPHERAL VASCULAR DISORDERS | PERIPHERAL VASCULAR DISORDERS | ||||
| Jan 2017 to Dec 2017 | Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017 | Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017 | Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017 | Jan 2013 to Dec 2017 | |
| Total Hospitalizations | 181 | 870 | 99 | 483 | 48 | 235 | 34 | 152 |
| Total Hospitalizations After Exclusion | 172 | 821 | 93 | 464 | 46 | 215 | 33 | 142 |
| Avg. LOS | 4.10 | 4.42 | 3.87 | 4.16 | 5.79 | 6.17 | 2.38 | 2.55 |
| All Cause Readmission Rate (%) | ||||||||
| Unplanned Readmission Rate (%) | ||||||||
| ICU Stays | ||||||||
| Avg. Number of Days in ICU per ICU Stay | ||||||||
| Total Medicare Payments | $1,557,819 | $8,154,220 | $780,025 | $4,175,552 | $590,784 | $3,116,383 | $187,009 | $862,284 |
| Payment per Day | $2,099 | $2,119 | $2,036 | $2,077 | $2,125 | $2,147 | $2,308 | $2,228 |
| Payment per Hospitalization | $8,606 | $9,372 | $7,879 | $8,645 | $12,308 | $13,261 | $5,500 | $5,672 |
| Total Medicare Charges | $6,149,265 | $33,438,065 | $3,010,082 | $16,832,672 | $2,273,222 | $12,757,070 | $865,961 | $3,848,323 |
| Avg. Charges | $33,974 | $38,435 | $30,405 | $34,850 | $47,359 | $54,285 | $25,469 | $25,318 |
| Mortality Rate (%) | ||||||||
| SNF Discharge Rate (%) | 20.44 | 22.87 | 19.19 | 22.98 | 27.08 | 28.94 | NA | 13.16 |
| Home Discharge Rate (%) | 31.49 | 32.76 | 30.30 | 31.68 | 25.00 | 23.83 | 44.12 | 50.00 |
| Peripheral Vascular Disease | ||||||||
| Total Hospitalizations with Peripheral Vascular Disease | ||||||||
| Total Hospitalizations After Exclusion with Peripheral Vascular Disease | ||||||||
| Avg. LOS with Peripheral Vascular Disease | ||||||||
| 30 Day Peripheral Vascular Disease Readmission Rate (%) | ||||||||
| 30 Day Readmission Rate with Peripheral Vascular Disease(%) | ||||||||
| 30 Day Peripheral Vascular Disease Unplanned Readmission Rate (%) | ||||||||
| ICU Stays with Peripheral Vascular Disease | ||||||||
| Avg. Number of Days in ICU per ICU Stay with Peripheral Vascular Disease | ||||||||
| Medicare Payments with Peripheral Vascular Disease | ||||||||
| Payment per Day with Peripheral Vascular Disease | ||||||||
| Payment per Hospitalization with Peripheral Vascular Disease | ||||||||
| Medicare Charges with Peripheral Vascular Disease | ||||||||
| Avg. Charges with Peripheral Vascular Disease | ||||||||
| Inpatient Hospital Mortality Rate (%) with Peripheral Vascular Disease | ||||||||
| SNF Discharge Rate (%) with Peripheral Vascular Disease | ||||||||
| Home Discharge Rate (%) with Peripheral Vascular Disease | ||||||||
| Incidence Rate (%) with Peripheral Vascular Disease | ||||||||
| Incidence Rate (%) with Peripheral Vascular Disease after Exclusions | ||||||||
Top ICD Diagnosis Codes for PERIPHERAL VASCULAR DISORDERS | Back to Reimbursement Quality Outcomes Summary
Data with Symbol is for Dexur Pro Members. Get a Demo and know more.
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | Total ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume - Jan 2013 to Dec 2017 | % of DRG Volume - Jan 2017 to Dec 2017 |
|---|---|---|---|---|---|
| 4019 | Unspecified essential hypertension | 233 | NA | 26.78 | NA |
Top Procedure Codes for PERIPHERAL VASCULAR DISORDERS | Back to Reimbursement Quality Outcomes Summary
Data with Symbol is for Dexur Pro Members. Get a Demo and know more.
| Procedure Code | Procedure Code Description | Total Procedure Code & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | Total Procedure Code & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume - Jan 2013 to Dec 2017 | % of DRG Volume - Jan 2017 to Dec 2017 |
|---|---|---|---|---|---|
| 9919 | 46 | NA | 5.29 | NA | |
Physicians Who May Use SCANLAN INTERNATIONAL INC - SCANLAN® In Situ Valvulotomes Back to Top
This sample data is for Yale New Haven Hospital & shows the top physicians that may be impacted by use of SCANLAN® In Situ Valvulotomes by SCANLAN INTERNATIONAL INC.
To get physicians impacted for your Hospital, click here.
Data from Medicare Claims Analysis
| Physician Name | Total Hospitalizations - Jan 2013 to Dec 2017 | Total Hospitalizations - Jan 2017 to Dec 2017 |
|---|---|---|
| DR. CARLOS I MENA-HURTADO | 61 | 12 |
| DR. JOHN A ELEFTERIADES | 15 | NA |
| DR. CASSIUS IYAD N OCHOA CHAAR | 13 | NA |